Insider · CIK 0002122447
Darren Charlton Smith
Files at TLX (Telix Pharmaceuticals Ltd). First filing Sep 14, 2026, latest Sep 14, 2026.
In brief
Darren Charlton Smith files SEC Form 4 as CFO at TLX (Telix Pharmaceuticals Ltd). Since Sep 14, 2026, Darren Charlton Smith has reported 1 open-market buy worth $20k and 0 open-market sells worth $0, the latest filed on Sep 14, 2026.
A track record needs three past buys with six months of prices behind them; Darren Charlton Smith has 0, so none is measured yet.
The newest scored trade: bought $20k of TLX on Sep 7, 2026, filed Sep 14, 2026, scored 25 (weak). In the last 12 months: 1 buy worth $20k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TLX: Telix Pharmaceuticals Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | TLXbuy Telix Pharmaceuticals Ltd | $20k 2,071 shares | +17% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 7, 2026 | TLX Telix Pharmaceuticals Ltd | POpen-market purchase Ordinary Shares | +2,071 | $9.66 | $20k | 13,992 | 29 d ago |
| Mar 29, 2026 | TLX Telix Pharmaceuticals Ltd | MOption exercise Ordinary Shares | +1,111 | $0.00 | $0 | 11,921 | Apr 1, 2026 |
| Mar 29, 2026 | TLX Telix Pharmaceuticals Ltd | MOption exercise Share Rightsderivative | -1,111 | $0.00 | $0 | 0 | Apr 1, 2026 |
Questions about Darren Charlton Smith
Answered from the filings on this page, as of the latest one.
Is Darren Charlton Smith buying or selling?
In the last 12 months Darren Charlton Smith reported 1 open-market buy worth $20k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20k of TLX on Sep 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Darren Charlton Smith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Darren Charlton Smith has 0.
Where does Darren Charlton Smith file Form 4?
Darren Charlton Smith has filed Form 4 at TLX (Telix Pharmaceuticals Ltd) as Group Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.